Epigenetic memory in induced pluripotent stem cells.

Nature
K KimGeorge Q Daley

Abstract

Somatic cell nuclear transfer and transcription-factor-based reprogramming revert adult cells to an embryonic state, and yield pluripotent stem cells that can generate all tissues. Through different mechanisms and kinetics, these two reprogramming methods reset genomic methylation, an epigenetic modification of DNA that influences gene expression, leading us to hypothesize that the resulting pluripotent stem cells might have different properties. Here we observe that low-passage induced pluripotent stem cells (iPSCs) derived by factor-based reprogramming of adult murine tissues harbour residual DNA methylation signatures characteristic of their somatic tissue of origin, which favours their differentiation along lineages related to the donor cell, while restricting alternative cell fates. Such an 'epigenetic memory' of the donor tissue could be reset by differentiation and serial reprogramming, or by treatment of iPSCs with chromatin-modifying drugs. In contrast, the differentiation and methylation of nuclear-transfer-derived pluripotent stem cells were more similar to classical embryonic stem cells than were iPSCs. Our data indicate that nuclear transfer is more effective at establishing the ground state of pluripotency than fa...Continue Reading

References

Oct 1, 1983·Cell·L C SkowS E Lewis
Sep 11, 1998·Nature·S EdenA W Thorne
May 2, 2001·Proceedings of the National Academy of Sciences of the United States of America·K EgganR Jaenisch
Oct 13, 2001·Genome Biology·P Pavlidis, W S Noble
Jan 11, 2002·Developmental Biology·Fátima SantosWendy Dean
Dec 20, 2002·Nucleic Acids Research·Eugene Y KohGeorge Q Daley
Sep 19, 2003·Genomics·George KirovMichael J Owen
Mar 15, 2005·FEBS Letters·Carolina Perez-IratxetaMiguel A Andrade
Aug 10, 2005·PLoS Biology·Luciano ContiAustin Smith
Jan 19, 2006·Proceedings of the National Academy of Sciences of the United States of America·Tobias BrambrinkRudolf Jaenisch
Jun 8, 2007·Nature·Keisuke OkitaShinya Yamanaka
Oct 18, 2007·Proceedings of the National Academy of Sciences of the United States of America·Bernhard SchiedlmeierHannes Klump
Jan 30, 2008·Current Protocols in Cell Biology·Brigitte WdziekonskiChristian Dani
Feb 19, 2008·Nature Biotechnology·Kenji OsafuneDouglas A Melton
Mar 5, 2008·Genome Research·Rafael A IrizarryAndrew P Feinberg
Mar 29, 2008·Cell Stem Cell·Claudia LengerkeGeorge Q Daley
May 30, 2008·Nature·Tarjei S MikkelsenAlexander Meissner
Jul 3, 2008·Nature Biotechnology·Marius WernigRudolf Jaenisch
Sep 13, 2008·Cell Stem Cell·Nimet MaheraliKonrad Hochedlinger
Oct 1, 1948·Stain Technology·R C W S HOOD, W M NEILL
Dec 20, 2008·Science·J B Gurdon, D A Melton
Jan 20, 2009·Nature Biotechnology·Styliani MarkoulakiRudolf Jaenisch
Feb 11, 2009·Cell·Jeong Beom KimHans R Schöler
Mar 7, 2009·Cell Stem Cell·George Q DaleyShinya Yamanaka
Mar 21, 2009·Blood·Yuin-Han LohGeorge Q Daley
Mar 31, 2009·Nature Biotechnology·Madeleine P BallGeorge M Church
Jul 11, 2009·Nature Biotechnology·Kyoko MiuraShinya Yamanaka
Aug 12, 2009·Nature·Han LiManuel Serrano
Oct 15, 2009·Nature Biotechnology·Elayne M ChanThorsten M Schlaeger

❮ Previous
Next ❯

Citations

Apr 25, 2012·Cellular and Molecular Life Sciences : CMLS·Masaaki KitadaMari Dezawa
Jan 1, 2013·Cellular and Molecular Life Sciences : CMLS·Kei Miyamoto, J B Gurdon
May 31, 2012·Journal of Molecular Medicine : Official Organ of the Gesellschaft Deutscher Naturforscher Und Ärzte·Katharina DrewsJames Adjaye
Jan 13, 2011·Archives of Toxicology·Anna M Wobus, Peter Löser
Apr 5, 2011·Seminars in Immunopathology·Suzanne Kadereit, Alan Trounson
Mar 2, 2011·Functional & Integrative Genomics·R AppelsM Bellgard
May 15, 2013·Bulletin of Experimental Biology and Medicine·S P MedvedevS M Zakian
Aug 22, 2013·Biogerontology·Phetcharat PhanthongAndras Dinnyes
Nov 10, 2011·Pharmaceutical Research·Amy BrockYuin-Han Loh
Jul 4, 2012·Current Diabetes Reports·Insa S Schroeder
Oct 17, 2012·Current Diabetes Reports·Hironori WakiTakashi Kadowaki
Jun 28, 2011·Stem Cell Reviews and Reports·Shizuka UchidaThomas Braun
Oct 14, 2011·Stem Cell Reviews and Reports·Richard D W KellyJustin C St John
Aug 8, 2012·Stem Cell Reviews and Reports·Andrea PreitschopfMario Mikula
Oct 23, 2013·Molecular Biotechnology·Katarzyna SkowronPiotr Czekaj
May 24, 2012·International Journal of Hematology·Zhaohui YeLinzhao Cheng
Nov 10, 2010·Journal of Cardiovascular Translational Research·Steven J KattmanBlake D Anson
Jan 6, 2011·Journal of Cardiovascular Translational Research·Almudena Martinez-FernandezAndre Terzic
Oct 17, 2012·Journal of Cardiovascular Translational Research·Kenta NakamuraSean M Wu
May 30, 2013·Journal of Physiology and Biochemistry·Anangi BalasiddaiahRafael Aldabe
Jun 25, 2013·Differentiation; Research in Biological Diversity·Nobuhiro ShimozawaYasuhiro Yasutomi
Jan 10, 2013·Experimental Neurology·Fahad AliRoger A Barker
Oct 3, 2013·Reproductive Biomedicine Online·Roger G Gosden
Nov 3, 2010·Cell Stem Cell·María J BarreroJuan Carlos Izpisúa Belmonte
Dec 10, 2013·Cell Stem Cell·Justine D MillerLorenz Studer
Nov 22, 2013·Journal of Proteome Research·Putty-Reddy SudhirChung-Hsuan Chen
Sep 17, 2010·Nature·Thomas P Zwaka
Feb 5, 2011·Nature·Elie Dolgin
May 20, 2011·Nature·Erika Check Hayden
Jan 11, 2012·Asian Journal of Andrology·Claudia GundackerMarkus Hengstschläger

❮ Previous
Next ❯

Methods Mentioned

BETA
CHARM

Software Mentioned

CHARM

Related Concepts

Related Feeds

Cell Fate Conversion By mRNA

mRNA-based technology is being studied as a potential technology that could be used to reprogram cell fate. This technique provides the potential to generate safe reprogrammed cells that can be used for clinical applications. Here is the latest research on cell fate conversion by mRNA.